Nuvectis Pharma, Inc. — Director's Dealing 2025

May 12, 2025

SEC Form 4/A — Form 4/A

Issuer: Nuvectis Pharma, Inc. (NVCT)
CIK: 0001875558
Period of Report: 2025-05-06

Reporting Person: Mosseri Marlio Charles (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-05-08	Common Stock	P	100	$8.99	Acquired	2909032	Indirect
2025-05-08	Common Stock	P	100	$8.71	Acquired	2909132	Indirect
2025-05-08	Common Stock	P	2400	$8.97	Acquired	2911532	Indirect
2025-05-09	Common Stock	P	9850	$8.947	Acquired	2921382	Indirect
2025-05-09	Common Stock	P	9817	$8.9041	Acquired	2931199	Indirect
2025-05-09	Common Stock	P	5395	$8.9760	Acquired	2936594	Indirect

Footnotes

F1: Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL.

F2: The original Form 4, filed on May 9, 2025, is being amended by this Form 4 amendment to correct the price of securities acquired by the reporting in the reported transactions.

F3: The original Form 4, filed on May 9, 2025, is being amended by this Form 4 amendment to include transactions that occurred on May 9, 2025.